For the Inventor, By the Inventor

Enter assignee name

St. Louis, MO, United States of America

Medibeacon Inc.

USPTO Granted Patents = 58

CIPO Patents = 1

EPO Patents = 11

Trademarks = 11

Forward Citations = 177

Loading Chart...

Loading Chart...

45 inventors (with patents filed for the assignee):

Richard Bradley Dorshow (34 out of 95 patents)

Raghavan Rajagopalan (25 out of 118 patents)

William L Neumann (21 out of 57 patents)

4. Dennis A Moore (9 out of 29 patents)

5. Thomas Edward Rogers (9 out of 54 patents)

6. Kate LeeAnn Bechtel (7 out of 85 patents)

7. Jennifer Keating (6 out of 6 patents)

8. Edward Gerald Solomon (6 out of 44 patents)

9. Kimberly Merritt Shultz (6 out of 15 patents)

10. Scott T Depierro (5 out of 6 patents)

11. Steven J Hanley (5 out of 5 patents)

12. Johannes Pill (5 out of 20 patents)

13. Daniel Schock-Kusch (5 out of 7 patents)

14. Phillip I Tarr (4 out of 4 patents)

15. Bob O Basore (4 out of 4 patents)

Core Competencies:

Fluorescent Tracer Agents

Transcutaneous Organ Function Measurement

Renal Function Determination

Optical Agents

Vascular Closure Devices

Gut Function Assessment

Eye Vasculature Assessment

Pyrazine Derivatives

Non-Invasive Monitoring

Tissue Sealant Compositions

Continuous Renal Replacement Therapy

Aromatic Systems

58 patents: Sort by Forward Citations

1. 12428382 - Purification of substituted diaminopyrazine dicarboxylic acids (2025-09-30),

2. 12319660 - Preparation of substituted diaminopyrazine dicarboxylic acids (2025-06-03),

3. 12303570 - Compositions and methods for assessing eye vasculature (2025-05-20),

4. 12257048 - Method for non-invasive monitoring of fluorescent tracer agent with diffuse reflecting medium with time-varying optical properties (2025-03-25),

5. 12257027 - Transcutaneous organ function measurement (2025-03-25),

6. D1052412 - Sensor (2024-11-26),

7. D1051738 - Sensor ring (2024-11-19),

8. 12102432 - Uses of transdermal glomerular filtration rate measurement in continuous renal replacement therapy (2024-10-01),

9. 12048751 - Compositions and methods for assessing gut function (2024-07-30),

10. 12036022 - Transcutaneous organ function measurement (2024-07-16),

11. 11969268 - Systems and methods for home transdermal assessment of gastrointestinal function (2024-04-30),

12. 11950907 - Method for non-invasive monitoring of fluorescent tracer agent with diffuse reflecting medium with time-varying optical properties (2024-04-09),

13. 11708336 - Anodic oxidation of 5-aminouracil (2023-07-25),

14. 11674965 - Method for preparing and analyzing fluorescent compounds in plasma (2023-06-13),

15. 11602570 - Compositions and systems for renal function determination (2023-03-14),

MediBeacon Inc. is a medical technology company that specializes in cutting-edge fluorescence imaging and sensing technologies. Our mission is to provide real-time, noninvasive medical monitoring solutions for healthcare professionals and patients. We develop innovative products that leverage the unique properties of light to improve disease diagnosis, treatment, and patient care. With a dedicated team of scientists, engineers, and healthcare experts, we strive to revolutionize healthcare through advanced optical technologies. Visit our website to learn more about our groundbreaking innovations and solutions.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

58 Patents

#39 in St. Louis, MO

#70 in Missouri

#5,957 in US

#12,003 in the World

St. Louis, MO, United States of America

Medibeacon Inc.

Forward Citations = 177

45 inventors:

Richard Bradley Dorshow (34 out of 95 patents)

Raghavan Rajagopalan (25 out of 118 patents)

William L Neumann (21 out of 57 patents)

4. Dennis A Moore (9 out of 29 patents)

5. Thomas Edward Rogers (9 out of 54 patents)

Please report any incorrect information to support@idiyas.com

Loading…